Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

June 01, 2015; Volume 12,Issue 2

Editorial

  • You have access
    PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors
    Rafael Rosell and Ramón Palmero
    Cancer Biology & Medicine June 2015, 12 (2) 71-73; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0026
  • You have access
    Tumor immune microenvironment characterization and response to anti-PD-1 therapy
    Mariacarmela Santarpia and Niki Karachaliou
    Cancer Biology & Medicine June 2015, 12 (2) 74-78; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0022

Review

  • You have access
    Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints
    Niki Karachaliou, Maria Gonzalez Cao, Cristina Teixidó, Santiago Viteri, Daniela Morales-Espinosa, Mariacarmela Santarpia and Rafael Rosell
    Cancer Biology & Medicine June 2015, 12 (2) 79-86; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0029
  • You have access
    Assays for predicting and monitoring responses to lung cancer immunotherapy
    Cristina Teixidó, Niki Karachaliou, Maria González-Cao, Daniela Morales-Espinosa and Rafael Rosell
    Cancer Biology & Medicine June 2015, 12 (2) 87-95; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0019
  • You have access
    Current approaches in treatment of triple-negative breast cancer
    Hanan Ahmed Wahba and Hend Ahmed El-Hadaad
    Cancer Biology & Medicine June 2015, 12 (2) 106-116; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0030

Original Article

  • You have access
    Changes in tumor-antigen expression profile as human small-cell lung cancers progress
    Li-Sheng Ge, Neil T. Hoa, Nils Lambrecht, Maria Dacosta-Iyer, Yi Ouyang, Amir Abolhoda and Martin R. Jadus
    Cancer Biology & Medicine June 2015, 12 (2) 96-105; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0027
  • You have access
    Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases
    Yue-Ya Li, Chan Zhou, Deng-Xia Yang, Jing Wang, Zhu-Jun Liu, Xin-Yue Wang and Kai Li
    Cancer Biology & Medicine June 2015, 12 (2) 117-125; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0012
  • You have access
    Predictive value of K-ras and PIK3CA in non-small cell lung cancer patients treated with EGFR-TKIs: a systemic review and meta-analysis
    Jie-Ying Chen, Ya-Nan Cheng, Lei Han, Feng Wei, Wen-Wen Yu, Xin-Wei Zhang, Shui Cao and Jin-Pu Yu
    Cancer Biology & Medicine June 2015, 12 (2) 126-139; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0021
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 12 (2)
Cancer Biology & Medicine
Vol. 12, Issue 2
1 Jun 2015
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Editorial
  • Review
  • Original Article

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire